The discussion will examine the growing threat of antimicrobial resistance in oncology settings, the role of medical nutrition in improving outcomes and quality of life, and persistent challenges to patient safety across treatment pathways.
Throughout, we will identify gaps, share best practices, and generate momentum for more integrated and resilient cancer care systems in Europe.
The event will be co-chaired by:
Alessandro Laviano, Professor at Sapienza University of Rome and Director of the European Society for Clinical Nutrition and Metabolism (ESPEN) Lifelong Learning Educational Programme; and
Ivana Dragojević, President of the Association for Liver Diseases Hronos and Vice-President of the European Liver Patients' Association (ELPA).
Please join us for what promises to be a most informative discussion.
15:00 - 15:10 | Welcome and introductions
15:10 - 15:55 | Medical Nutrition
To be co-chaired by Alessandro Laviano and Katrien Van Laere, Chief Medical & Scientific Officer at Danone.
This session will bring attention to the burden and under-recognition of cancer-related malnutrition, the role of medical nutrition, and the existing gaps in EU policy regarding this issue.
15:55 - 16:40 | Antimicrobial resistance
To be co-chaired by Alessandro Laviano and Najy Alsayed, Global Therapeutic Area Head for Infectious Diseases, Menarini.
The session will examine the impact of antimicrobial resistance for cancer care in Europe, the health economic aspect to its incidence and control and the political opportunities for improved response.
16:40 - 17:25 | Healthcare Acquired Infections
To be co-chaired by Ivana Dragojević, Vice-President and Treasurer, European Liver Patients' Association (ELPA) and Jose Luis Gomez Ruiz, Vice President Europe of Becton, Dickinson and Company (BD).
The session will consider some of the principal patient safety risks that can be present in oncology treatment with a special look at healthcare acquired infections. Practices to mitigate and prevent these risks from around the globe will be considered and discussed.
17:25 - 17:30 | Event conclusions